BACKGROUND: Invasive lobular carcinoma (ILC) comprises around 10 - 15% of invasive breast cancers. Few prior studies have demonstrated a unique pattern of metastases between ILC and the more common invasive ductal carcinoma (IDC). To our knowledge, such data is limited to first sites of distant recurrence. We aimed to perform a comparison of the metastatic pattern of ILC and IDC at first distant recurrence as well as over the entire course of metastatic disease. METHODS: We used a prospectively collated database of patients with metastatic breast cancer. Breast cancer recurrence or metastases were classified into various sites and a descriptive analysis was performed. RESULTS: Among 761 patients, 88 (11.6%) were diagnosed with ILC and 673 (88.4%) with IDC. Patients with ILC showed more frequent metastases to the bone (56.8 vs. 37.7%, p = 0.001) and gastrointestinal (GI) tract (5.7 vs. 0.3%, p < 0.001) as first site of distant recurrence, and less to organs such as lung (5.7 vs. 24.2%, p < 0.001) and liver (4.6 vs. 11.4%, p = 0.049). Over the entire course of metastatic disease, more patients with ILC had ovarian (5.7 vs. 2.1%, p = 0.042) and GI tract metastases (8.0 vs. 0.6%, p < 0.001), also demonstrating reduced tendency to metastasize to the liver (20.5 vs. 49.0%, p < 0.001) and lung (23.9 vs. 51.9%, p < 0.001). All associations but bone held after sensitivity analysis on hormonal status. Although patients presenting with ILC were noted to have more advanced stage at presentation, recurrence-free survival in these patients was increased (4.8 years vs. 3.2 years, p = 0.017). However, overall survival was not (2.5 vs. 2.0 years, p = 0.75). CONCLUSION: After accounting for hormone receptor status, patients with IDC had greater lung/pleura and liver involvement, while patients with ILC had a greater propensity to develop ovarian and GI metastases both at first site and overall. Clinicians can use this information to provide more directed screening for metastases; it also adds to the argument that these two variants of breast cancer should be managed as unique diseases.
BACKGROUND:Invasive lobular carcinoma (ILC) comprises around 10 - 15% of invasive breast cancers. Few prior studies have demonstrated a unique pattern of metastases between ILC and the more common invasive ductal carcinoma (IDC). To our knowledge, such data is limited to first sites of distant recurrence. We aimed to perform a comparison of the metastatic pattern of ILC and IDC at first distant recurrence as well as over the entire course of metastatic disease. METHODS: We used a prospectively collated database of patients with metastatic breast cancer. Breast cancer recurrence or metastases were classified into various sites and a descriptive analysis was performed. RESULTS: Among 761 patients, 88 (11.6%) were diagnosed with ILC and 673 (88.4%) with IDC. Patients with ILC showed more frequent metastases to the bone (56.8 vs. 37.7%, p = 0.001) and gastrointestinal (GI) tract (5.7 vs. 0.3%, p < 0.001) as first site of distant recurrence, and less to organs such as lung (5.7 vs. 24.2%, p < 0.001) and liver (4.6 vs. 11.4%, p = 0.049). Over the entire course of metastatic disease, more patients with ILC had ovarian (5.7 vs. 2.1%, p = 0.042) and GI tract metastases (8.0 vs. 0.6%, p < 0.001), also demonstrating reduced tendency to metastasize to the liver (20.5 vs. 49.0%, p < 0.001) and lung (23.9 vs. 51.9%, p < 0.001). All associations but bone held after sensitivity analysis on hormonal status. Although patients presenting with ILC were noted to have more advanced stage at presentation, recurrence-free survival in these patients was increased (4.8 years vs. 3.2 years, p = 0.017). However, overall survival was not (2.5 vs. 2.0 years, p = 0.75). CONCLUSION: After accounting for hormone receptor status, patients with IDC had greater lung/pleura and liver involvement, while patients with ILC had a greater propensity to develop ovarian and GI metastases both at first site and overall. Clinicians can use this information to provide more directed screening for metastases; it also adds to the argument that these two variants of breast cancer should be managed as unique diseases.
Entities:
Keywords:
breast cancer; distant; late recurrence; lobular carcinoma; metastasis; survival
Authors: P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve Journal: Nature Date: 1998-03-26 Impact factor: 49.962
Authors: Bernhard C Pestalozzi; David Zahrieh; Elizabeth Mallon; Barry A Gusterson; Karen N Price; Richard D Gelber; Stig B Holmberg; Jurij Lindtner; Raymond Snyder; Beat Thürlimann; Elizabeth Murray; Giuseppe Viale; Monica Castiglione-Gertsch; Alan S Coates; Aron Goldhirsch Journal: J Clin Oncol Date: 2008-05-05 Impact factor: 44.544
Authors: Christopher I Li; Janet R Daling; Kara L Haugen; Mei Tzu Chen Tang; Peggy L Porter; Kathleen E Malone Journal: Breast Cancer Res Treat Date: 2014-04-20 Impact factor: 4.872
Authors: Elinor Sawyer; Rebecca Roylance; Christos Petridis; Mark N Brook; Salpie Nowinski; Efterpi Papouli; Olivia Fletcher; Sarah Pinder; Andrew Hanby; Kelly Kohut; Patricia Gorman; Michele Caneppele; Julian Peto; Isabel Dos Santos Silva; Nichola Johnson; Ruth Swann; Miriam Dwek; Katherine-Anne Perkins; Cheryl Gillett; Richard Houlston; Gillian Ross; Paolo De Ieso; Melissa C Southey; John L Hopper; Elena Provenzano; Carmel Apicella; Jelle Wesseling; Sten Cornelissen; Renske Keeman; Peter A Fasching; Sebastian M Jud; Arif B Ekici; Matthias W Beckmann; Michael J Kerin; Federick Marme; Andreas Schneeweiss; Christof Sohn; Barbara Burwinkel; Pascal Guénel; Therese Truong; Pierre Laurent-Puig; Pierre Kerbrat; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Roger L Milne; Jose Ignacio Arias Perez; Primitiva Menéndez; Javier Benitez; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Alfons Meindl; Peter Lichtner; Rita K Schmutzler; Magdalena Lochmann; Hiltrud Brauch; Hans-Peter Fischer; Yon-Dschun Ko; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Natalia V Bogdanova; Thilo Dörk; Annika Lindblom; Sara Margolin; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Georgia Chenevix-Trench; Diether Lambrechts; Caroline Weltens; Erik Van Limbergen; Sigrid Hatse; Jenny Chang-Claude; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Paolo Radice; Paolo Peterlongo; Bernardo Bonanni; Sara Volorio; Graham G Giles; Gianluca Severi; Laura Baglietto; Catriona A McLean; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Jacques Simard; Mark S Goldberg; France Labrèche; Martine Dumont; Vessela Kristensen; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Saila Kauppila; Irene L Andrulis; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Peter Devillee; Rob A E M Tollenaar; Caroline M Seynaeve; Mieke Kriege; Jonine Figueroa; Stephen J Chanock; Mark E Sherman; Maartje J Hooning; Antoinette Hollestelle; Ans M W van den Ouweland; Carolien H M van Deurzen; Jingmei Li; Kamila Czene; Keith Humphreys; Angela Cox; Simon S Cross; Malcolm W R Reed; Mitul Shah; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Anthony Swerdlow; Alan Ashworth; Nicholas Orr; Minouk Schoemaker; Fergus J Couch; Emily Hallberg; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Daniel C Tessier; Daniel Vincent; Francois Bacot; Manjeet K Bolla; Qin Wang; Joe Dennis; Kyriaki Michailidou; Alison M Dunning; Per Hall; Doug Easton; Paul Pharoah; Marjanka K Schmidt; Ian Tomlinson; Montserrat Garcia-Closas Journal: PLoS Genet Date: 2014-04-17 Impact factor: 5.917
Authors: Emily A Bossart; Nilgun Tasdemir; Matthew J Sikora; Amir Bahreini; Kevin M Levine; Jian Chen; Ahmed Basudan; Britta M Jacobsen; Timothy F Burns; Steffi Oesterreich Journal: Breast Cancer Res Treat Date: 2019-02-23 Impact factor: 4.872
Authors: Tian Du; Li Zhu; Kevin M Levine; Nilgun Tasdemir; Adrian V Lee; Dario A A Vignali; Bennett Van Houten; George C Tseng; Steffi Oesterreich Journal: Sci Rep Date: 2018-05-08 Impact factor: 4.379
Authors: Christine Desmedt; Julien Pingitore; Françoise Rothé; Caterina Marchio; Florian Clatot; Ghizlane Rouas; François Richard; François Bertucci; Odette Mariani; Christine Galant; Charlotte Fribbens; Ben O'Leary; Gert van den Eynden; Roberto Salgado; Nicholas C Turner; Martine Piccart; Anne Vincent-Salomon; Giancarlo Pruneri; Denis Larsimont; Christos Sotiriou Journal: NPJ Breast Cancer Date: 2019-02-22
Authors: E S Sokol; Y X Feng; D X Jin; A Basudan; A V Lee; J M Atkinson; J Chen; P J Stephens; G M Frampton; P B Gupta; J S Ross; J H Chung; S Oesterreich; S M Ali; R J Hartmaier Journal: Ann Oncol Date: 2019-01-01 Impact factor: 32.976
Authors: William A Nehmeh; Joseph Derienne; Léa El Khoury; Serge Kassar; Viviane Track-Smayra; Roger Noun; Ghassan Chakhtoura Journal: Am J Case Rep Date: 2021-04-08
Authors: Madeleine T Shackleford; Deviyani M Rao; Evelyn K Bordeaux; Hannah M Hicks; Christina G Towers; Joseph L Sottnik; Steffi Oesterreich; Matthew J Sikora Journal: Cancers (Basel) Date: 2020-10-12 Impact factor: 6.639